Publications – Urinary Tract, Sexual Health, Wound
Product Category | Product Code | Assay Name/Assay Targets | Publication Citation |
---|---|---|---|
Urinary Tract Infection, Sexually Transmitted Infection & Wound | 350-011-A-MAX 400-003-C-MAX 450-039-C-MAX | Mycoplasma-Ureaplasma | Ayaz ÇM et al. “Investigation of the Frequency of Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and Mycoplasma genitalium in Men Living with HIV in Terms of Sociodemographic Characteristics and Behavioral Risk Factors.” Mikrobiyol Bul. 2023 Jul;57(3):378-389. |
Kusanovic, Juan Pedro, et al. "Comparison of two identification and susceptibility test kits for Ureaplasma spp and Mycoplasma hominis in amniotic fluid of patients at high risk for intra-amniotic infection." The Journal of Maternal-Fetal & Neonatal Medicine 33.20 (2020): 3409-3417. | |||
Rosales-Castillo, Antonio, et al. "Emerging Presence of Culturable Microorganisms in Clinical Samples of the Genitourinary System: Systematic Review and Experience in Specialized Care of a Regional Hospital." Journal of clinical medicine 11.5 (2022): 1348. | |||
Van Der Pol, Barbara, et al. "P604 Platform-agnostic reagents for detection of mycoplasma genitalium." (2019): A267-A268. | |||
Siles-Guerrero, Víctor, et al. "Recent clinical relevance of mono-genital colonization/infection by Ureaplasma parvum." European Journal of Clinical Microbiology & Infectious Diseases 39 (2020): 1899-1905. | |||
Rosales-Castillo, Antonio, et al. "Presence and Relevance of Emerging Microorganisms in Clinical Genitourinary Samples." Microorganisms 11.4 (2023): 915. | |||
Chromy, David, et al. "High cure rates of Mycoplasma genitalium following empiric treatment with azithromycin alongside frequent detection of macrolide resistance in Austria." Infection (2024): 1-10. | |||
Ruiz Del Pino, M., et al. "Isolation of Haemophilus no ducreyi in samples from the genital tract of men: Its clinical relationship." Revista Internacional de Andrologia 21.4 (2023): 100374-100374 | |||
Defossez, A., et al. “Evaluation of a new syndromic panel (STI, Vivalytic BOSCH®) in the diagnosis of STIs.” Medicine and Infectious Diseases Training 3.2 (2024): S97-S98. | |||
Védy S. et al. "Evaluation d'une PCR en temps réel pour la quantification des mycoplasmes uro-génitaux : A propos de la PCR M. hominis, U.urealyticum, U. parvum développée par la société BioGX® pour l'automate BD MAX ® (Société BD)", Poster (2017), Laboratoire Ketterthill, Luxembourg | |||
Van der Pol B. et al. "Platform Agnostic Reagents for Detection of Mycoplasma genitalium", Poster (2019), University of Alabama, United States | |||
Chandrasekaran S. et al. "Evaluation Of A Multiplex Real Time PCR Assay For The Detection Of Mycoplasma and Ureaplasma species At A Large Tertiary Care Facility", Poster (2018), School of Medicine, University of California Los Angeles, Los Angeles, CA, United States | |||
ÇALIŞKAN, Zeynep, et al. Determination of Gene Mutations Associated with Macrolide and Fluoroquinolone Resistance in Patients Infected with Mycoplasma genitalium_ Microbiology Bülteni 58.4 (2024) | |||
350-070-C-MAX 450-043-C-MAX | Candida auris | Contreras, Deisy A., and Margie A. Morgan. "Surveillance diagnostic algorithm using real-time PCR assay and strain typing method development to assist with the control of C. auris amid COVID-19 pandemic." Frontiers in Cellular and Infection Microbiology (2022): 1053. | |
Lockhart, Shawn R., Meghan M. Lyman, and D. Joseph Sexton. "Tools for Detecting a “Superbug”: Updates on Candida auris Testing." Journal of Clinical Microbiology (2022): e00808-21. | |||
Morgan M., Contreras Deisy A. "Combating Candida auris Outbreak Amidst COVID-19 Pandemic" Poster (2022) Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, United States | |||
Wong C. et al "Assessing the limit of detection of Candida auris screening methods using direct-to-agar, broth-enriched-culture, direct-polymerase chain reaction, and broth-enriched-polymerase chain reaction, Poster (2022), Sinai Hospital, University of Toronto | |||
Arenas, Sebastian, et al. "Operational impact of decreased turnaround times for Candida auris screening tests in a tertiary academic medical center." Antimicrobial Stewardship & Healthcare Epidemiology 3.1 (2023): e176. | |||
Arenas, Sebastian P., et al. "Persistent colonization of Candida auris among inpatients rescreened as part of a weekly surveillance program." Infection Control & Hospital Epidemiology (2023): 1-4. | |||
Arena, Fabio, Paola Bernaschi, and Antonella Mencacci. "Clinical impact of fast platforms and laboratory automation for the rapid diagnosis of infectious diseases and detection of antimicrobial resistance determinants." Frontiers in Cellular and Infection Microbiology 13 (2023). | |||
Banik, Sukalyani, et al. "A simple and sensitive test for Candida auris colonization, surveillance, and infection control suitable for near patient use." Journal of Clinical Microbiology (2024): e00525-24. | |||
Wong, River Chun-Wai, et al. "Current Updates on Molecular Diagnostic Assays Used for Detection of Candida auris: A Systematic Review." Diagnostics 15.2 (2025): 140. | |||
Custom manufactured assay | Candida auris | Evans D. et al. "Capture It Before It Is Too Late. Design and Validation of a Rapid PCR Laboratory Developed Test (LDT) for Detecting Candida auris in Swabs Collected from Groin and Axilla." Poster (2024) Advent Health, Orlando, Florida, United States |